Prometheus Biosciences, Inc.

Feb 16, 2021

Prometheus Biosciences Announces Appointments of Judith L. Swain, MD and Helen C. Adams, CPA to its Board of Directors

Nov 09, 2020

Prometheus Biosciences Announces $130 Million Financing to Advance Precision Medicines for the Treatment of Inflammatory Bowel Disease

Sep 29, 2020

Prometheus Biosciences Appoints Olivier Laurent, Ph.D. as Chief Technology Officer

Aug 25, 2020

Prometheus Biosciences Appoints Joseph C. Papa to its Board of Directors

Aug 13, 2020

Prometheus Biosciences and Dr. Falk Pharma GmbH Announce Global Collaboration Agreement to Develop and Commercialize a Novel IBD Antibody

Aug 04, 2020

Prometheus Biosciences Appoints Keith W. Marshall as Chief Financial Officer

Mar 23, 2020

Prometheus Biosciences Launches Monitr(TM) COVID-19 Assistance Program (M.C.A.P.)